Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery

Journal of Drug Targeting

Volumn 20, Issue 4, 2012, Pages 347-354

  Briane, Dominique ^a   Slimani, Hocine ^a   Tagounits, Arezki ^a   Naejus, Regine ^b   Haddad, Oualid ^a   Coudert, Robert ^b   Charnaux, Nathalie ^a   Cao, An ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

cancer cells; DMHAPC Chol cationic liposomes; small interfering RNA; vascular endothelial growth factor

Indexed keywords

CATION; CHOLESTEROL DERIVATIVE; DIMETHYLHYDROXYETHYLAMINOPROPANECARBAMOYLCHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOFECTAMINE; LIPOSOME; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSPORT;

CATIONS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; DNA; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; GREEN FLUORESCENT PROTEINS; HUMANS; LIPOSOMES; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859538044     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.656645     Document Type: Article

References (33)

1. Akhtar S, Benter IF. (2007). Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest, 117, 3623-3632. (Pubitemid 350224068)
2. Arthanari Y, Pluen A, Rajendran R, Aojula H, Demonacos C. (2010). Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells. J Control Release, 145, 272-280.
3. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM. (2001). Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res, 61, 5736-5740. (Pubitemid 32769088)
4. Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. (2002). Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun, 296, 1000-1004.
5. Caplen NJ. (2003). RNAi as a gene therapy approach. Expert Opin Biol Ther, 3, 575-586.
6. Ding W, Hattori Y, Higashiyama K, Maitani Y. (2008). Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. Int J Pharm, 354, 196-203.
7. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498. (Pubitemid 32494397)
8. Ferrara N. (2002). VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer, 2, 795-803.
9. Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, Harel-Bellan A, Clézardin P, Cabon F. (2003). SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res, 63, 3919-3922. (Pubitemid 36917906)
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811. (Pubitemid 28099681)
11. Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-1186.
12. Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1, 27-31.
13. Hammond SM, Bernstein E, Beach D, Hannon GJ. (2000). An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 404, 293-296. (Pubitemid 30163547)
14. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. (2008). Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release, 129, 107-116.
15. Lange T, Guttmann-Raviv N, Baruch L, Machluf M, Neufeld G. (2003). VEGF162, a new heparin-binding vascular endothelial growth factor splice form that is expressed in transformed human cells. J Biol Chem, 278, 17164-17169. (Pubitemid 36799595)
16. Lares MR, Rossi JJ, Ouellet DL. (2010). RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol, 28, 570-579.
17. Lee RJ, Huang L. (1997). Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst, 14, 173-206. (Pubitemid 27169246)
18. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309. (Pubitemid 20066716)
19. Matsumoto K, Kubo H, Murata H, Uhara H, Takata M, Shibata S, Yasue S, Sakakibara A, Tomita Y, Kageshita T, Kawakami Y, Mizuno M, Yoshida J, Saida T. (2008). A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. Jpn J Clin Oncol, 38, 849-856.
20. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD. (1991). Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA, 88, 5819-5823. (Pubitemid 21914837)
21. Percot A, Briane D, Coudert R, Reynier P, Bouchemal N, Lièvre N, Hantz E, Salzmann JL, Cao A. (2004). A hydroxyethylated cholesterolbased cationic lipid for DNA delivery: effect of conditioning. Int J Pharm, 278, 143-163. (Pubitemid 38670445)
22. Reynier P, Briane D, Coudert R, Fadda G, Bouchemal N, Bissieres P, Taillandier E, Cao A. (2004). Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours. J Drug Target, 12, 25-38. (Pubitemid 38584884)
23. Schatzlein AG. (2001). Non-viral vectors in cancer gene therapy: principles and progress. Anticancer Drugs, 12, 275-304.
24. Scott PA, Gleadle JM, Bicknell R, Harris AL. (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer, 75, 706-712. (Pubitemid 28145817)
25. Shi W, Siemann DW. (2004). Simultaneous targeting of VEGF message and VEGF receptor signaling as a therapeutic anticancer approach. Anticancer Res, 24, 213-218. (Pubitemid 38279710)
26. Slimani H, Guenin E, Briane D, Coudert R, Charnaux N, Starzec A, Vassy R, Lecouvey M, Perret YG, Cao A. (2006). Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1. J Drug Target, 14, 694-706. (Pubitemid 44921528)
27. Sørensen DR, Leirdal M, Sioud M. (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 327, 761-766. (Pubitemid 36315917)
28. Spelios M, Kearns M, Savva M. (2010). From gene delivery to gene silencing: plasmid DNA-transfecting cationic lipid 1,3-dimyristoylamidopropane- 2-[bis(2-dimethylaminoethane)] carbamate efficiently promotes small interfering RNA-induced RNA interference. Biochemistry, 49, 5753-5759.
29. Stein CA, Hansen JB, Lai J, Wu S, Voskresenskiy A, Høg A, Worm J, Hedtjärn M, Souleimanian N, Miller P, Soifer HS, Castanotto D, Benimetskaya L, Ørum H, Koch T. (2010). Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res, 38, e3.
30. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. (2004). A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res, 64, 3365-3370. (Pubitemid 38657905)
31. Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M, Saito R, Nobayashi M, Wakabayashi T. (2004). Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum Gene Ther, 15, 77-86. (Pubitemid 38147190)
32. Zabner J. (1997). Cationic lipids used in gene transfer. Adv Drug Deliv Rev, 27, 17-28.
33. Zetter BR. (1998). Angiogenesis and tumor metastasis. Annu Rev Med, 49, 407-424.